New studies on respiratory syncytial virus (RSV) in both adults and young children show that infections are linked to a ...

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our infants with vaccination.

Researchers from the Wesfarmers Center of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, ...

Many people recover quickly, but RSV can lead to more severe respiratory illness in infants, young children, and adults over the age of 65 years. RSV is a leading cause of pneumonia and bronchitis ...

In this cohort study of children hospitalized with respiratory syncytial virus (RSV) in 2022 and 2023, severe RSV disease was more likely among those age 2 or older with pulmonary and neurologic, ...

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

The long-acting Respiratory Syncytial Virus (RSV) immunisation is now available free for eligible families until September 30 ...

The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the ...

Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...